G.D. Nossent

544 total citations
8 papers, 309 citations indexed

About

G.D. Nossent is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Infectious Diseases. According to data from OpenAlex, G.D. Nossent has authored 8 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 2 papers in Surgery and 1 paper in Infectious Diseases. Recurrent topics in G.D. Nossent's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Viral gastroenteritis research and epidemiology (1 paper) and Respiratory viral infections research (1 paper). G.D. Nossent is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Viral gastroenteritis research and epidemiology (1 paper) and Respiratory viral infections research (1 paper). G.D. Nossent collaborates with scholars based in Netherlands, Australia and Germany. G.D. Nossent's co-authors include Marc J. M. Bonten, Steven Thijsen, Eelko Hak, M. M. E. Schneider, Anton M. van Loon, Andy I. M. Hoepelman, Jan Jelrik Oosterheert, Rob Schuurman, Martine Loeve and Peter Th. W. van Hal and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and Annals of Oncology.

In The Last Decade

G.D. Nossent

6 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.D. Nossent Netherlands 5 145 140 59 31 25 8 309
Hajime Fukuyama Japan 10 129 0.9× 189 1.4× 44 0.7× 15 0.5× 63 2.5× 13 396
Yasuyoshi Washio Japan 10 135 0.9× 108 0.8× 29 0.5× 22 0.7× 15 0.6× 21 260
Susana Melendo Spain 9 102 0.7× 32 0.2× 111 1.9× 17 0.5× 12 0.5× 34 209
A. I. M. Hoepelman Netherlands 12 172 1.2× 24 0.2× 108 1.8× 25 0.8× 9 0.4× 21 349
Petre Iacob Calistru Romania 10 105 0.7× 43 0.3× 27 0.5× 12 0.4× 23 0.9× 25 231
Zoe Weiss United States 10 165 1.1× 34 0.2× 134 2.3× 28 0.9× 6 0.2× 24 278
Shih‐Wei Lee Taiwan 10 89 0.6× 82 0.6× 64 1.1× 23 0.7× 27 1.1× 25 304
Mia Furebring Sweden 10 143 1.0× 26 0.2× 53 0.9× 11 0.4× 8 0.3× 26 314
Alessandro Porta Italy 9 135 0.9× 53 0.4× 53 0.9× 6 0.2× 17 0.7× 17 320
Prabhu Shankar United States 7 209 1.4× 66 0.5× 61 1.0× 3 0.1× 10 0.4× 14 291

Countries citing papers authored by G.D. Nossent

Since Specialization
Citations

This map shows the geographic impact of G.D. Nossent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.D. Nossent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.D. Nossent more than expected).

Fields of papers citing papers by G.D. Nossent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.D. Nossent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.D. Nossent. The network helps show where G.D. Nossent may publish in the future.

Co-authorship network of co-authors of G.D. Nossent

This figure shows the co-authorship network connecting the top 25 collaborators of G.D. Nossent. A scholar is included among the top collaborators of G.D. Nossent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.D. Nossent. G.D. Nossent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Nossent, Esther J., G.D. Nossent, Lilian J. Meijboom, et al.. (2024). Recurrent Pulmonary Veno-Occlusive Disease after Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 210(11). 1370–1373.
2.
Boorsma, Carian E., Christina Draijer, Robbert H. Cool, et al.. (2014). A Possible Role For The Rank/rankl/opg Axis In Pulmonary Fibrosis. Data Archiving and Networked Services (DANS). 189. 2 indexed citations
3.
Brouwers, Adrienne H., Elke S. Hoendermis, Rudi Dierckx, et al.. (2013). Size of pulmonary embolism in relation to persisting symptoms. University of Groningen research database (University of Groningen / Centre for Information Technology). 11. 758–758.
4.
Loeve, Martine, Peter Th. W. van Hal, Philip Robinson, et al.. (2009). The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease. Thorax. 64(10). 876–882. 68 indexed citations
5.
Oosterheert, Jan Jelrik, Anton M. van Loon, Rob Schuurman, et al.. (2005). Impact of Rapid Detection of Viral and Atypical Bacterial Pathogens by Real-Time Polymerase Chain Reaction for Patients with Lower Respiratory Tract Infection. Clinical Infectious Diseases. 41(10). 1438–1444. 152 indexed citations
6.
Groen, Harry J.M., Eelco Fokkema, Paul R. Timmer, et al.. (2004). Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Annals of Oncology. 15(3). 427–432. 41 indexed citations
7.
Thiel, R., et al.. (1992). Articular Complications of Intravesical BCG Treatment for Bladder Carcinoma. British Journal of Urology. 70(4). 446–447. 13 indexed citations
8.
Ensing, Kees, Dick de Zeeuw, G.D. Nossent, G H Koëter, & P. J. G. Cornelissen. (1989). Pharmacokinetics of ipratropium bromide after single dose inhalation and oral and intravenous administration. European Journal of Clinical Pharmacology. 36(2). 189–194. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026